期刊文献+
共找到29篇文章
< 1 2 >
每页显示 20 50 100
应用荧光原位杂交检测人凝血因子Ⅸ在转基因小鼠染色体上的整合 被引量:12
1
作者 肖艳萍 奚鹰 +1 位作者 黄文英 黄英 《遗传》 CAS CSCD 北大核心 2002年第3期232-236,共5页
应用荧光原位杂交 (FISH)技术检测两个转基因小鼠家系从F1到F4 代的整合情况。阳性转基因小鼠 98%~ 10 0 %的中期分裂相 ,85 %~ 94%的间期核出现杂交信号 ;阴性对照小鼠 10 0 %的中期分裂相、95 %~ 96 %的间期核未出现杂交信号。结... 应用荧光原位杂交 (FISH)技术检测两个转基因小鼠家系从F1到F4 代的整合情况。阳性转基因小鼠 98%~ 10 0 %的中期分裂相 ,85 %~ 94%的间期核出现杂交信号 ;阴性对照小鼠 10 0 %的中期分裂相、95 %~ 96 %的间期核未出现杂交信号。结果表明 ,该FISH实验条件能对转基因整合位点进行高效特异检测。本文分析的两家系转基因小鼠均为单位点整合 ,但整合位点不同。各家系内F1到F4 代的转基因小鼠均可检出整合染色体 ,且整合位点相同 ,表明外源基因稳定整合并遗传给后代。 展开更多
关键词 荧光原位杂交 检测 人凝血因子 转基因小鼠 染色体 整合位点
下载PDF
Expression of biologically active human clotting factor Ⅸ(hFⅨ) in the mammary gland of transgenic mice 被引量:2
2
作者 HUANG Ying ZHANG Kezhong +8 位作者 HUANG Wenying LU Daru HUANG Ying MA Zhanlu REN Zhaorui QIU Xinfang XUE Jinglun ZENG Yitao HUANG Shuzhen 《Chinese Science Bulletin》 SCIE CAS 1998年第15期1294-1298,共5页
The DNA of human factor Ⅸ (hFⅨ) gene vector pMCⅨm, which had been proven to be able to express in in vitro and living cells, was introduced into 586 zygotes of Kunming White Mice by positive pressure microinjection... The DNA of human factor Ⅸ (hFⅨ) gene vector pMCⅨm, which had been proven to be able to express in in vitro and living cells, was introduced into 586 zygotes of Kunming White Mice by positive pressure microinjection technique with manual operation. The 499 survival embryos after microinjection were then transferred into pseudopregnant recipient mice and 216 F 0 pups were born. The analysis of PCR and Southern blot hybridization showed that, of the 216, 6 (2 females and 4 males) were integrated with foreign DNA in their genomes, giving an integration frequency of 3% (6/216). Two F\-0 female transgenic mice could express hFⅨ protein in their milk and the content was over 100 ng/mL as measured with ELISA. The biological activities of hFⅨ in the milk of two F\-0 mice were 44 67% and 79 43%, respectively. 展开更多
关键词 human factor(hf) transgenic mice mammary gland expression.
原文传递
Human clotting factor Ⅸ (hF Ⅸ ) secretion in goat milk after direct transfer with hF Ⅸ minigene into mammary gland by using retroviral vectors 被引量:1
3
作者 ZHANG Kezhong, WANG Hongwei, BAO Yun, LU Daru,XUE Jinglun (J. L. Hsueh), QIU Xinfang, HUANG Shuzhen,HUANG Ying, LI Bingyan, LI Hua and ZENG Yitao1. Institute of Genetics, Fudan University, Shanghai 200433, China 2 Shanghai Children’s Hospital, Shanghai Institute of Medical Genetics, Shanghai 200040, China 《Chinese Science Bulletin》 SCIE EI CAS 1997年第15期1308-1313,共6页
THE mammary gland bioreactor system of lactating animal, established by germ-linemicroinjection and embryo transplantation, has been one of the most exciting projects in thefield of biotechnology. However, this system... THE mammary gland bioreactor system of lactating animal, established by germ-linemicroinjection and embryo transplantation, has been one of the most exciting projects in thefield of biotechnology. However, this system is costly, laborious and tim-cosuming. In 1994,Johanna et al. reported that secretion of a foreign protein, human growth hormone (hGH),in milk had been achieved after direct introduction of the cDNA into the mammary gland ofgoats by replication-defective retroviral vector. In that work, the in vivo expression of 展开更多
关键词 mammary-specific expression human clotting factor (hf ) RETROVIRAL vectors.
原文传递
逆转录病毒载体转染的人凝血因子Ⅸ基因在人脐带组织源间充质干细胞中的表达 被引量:3
4
作者 陈晓梨 董春兰 +8 位作者 冯小明 陈振萍 周泽平 许显辉 赵钦军 邱志勇 任倩 张蕾 韩忠朝 《中国实验血液学杂志》 CAS CSCD 2009年第1期184-187,共4页
为了研究逆转录病毒(pLEGFP-N1)转染的人凝血因子Ⅸ(hFⅨ)基因在人脐带间充质干细胞中的表达,应用DNA重组技术将hFⅨcDNA构建入pLEGFP-N1载体,转导入包装细胞系Pheonix细胞,应用病毒上清感染人脐带组织源间充质干细胞(hUCT-MSCs),经G41... 为了研究逆转录病毒(pLEGFP-N1)转染的人凝血因子Ⅸ(hFⅨ)基因在人脐带间充质干细胞中的表达,应用DNA重组技术将hFⅨcDNA构建入pLEGFP-N1载体,转导入包装细胞系Pheonix细胞,应用病毒上清感染人脐带组织源间充质干细胞(hUCT-MSCs),经G418筛选10天后获得全部的转染阳性细胞,从蛋白质水平和其功能活性上检测hFⅨ的表达。结果显示:配养上清液中可检测到hFⅨ的表达,每24小时分泌量达2.68±0.36μg/106细胞。Western blot检测表明,转导hFⅨ的hUCT-MSCs能分泌预期分子大小的hFⅨ入上清。功能性凝集测定实验表明了转导FⅨ的hUCT-MSCs2天培养上清中hFⅨ的活性为100%-130%。结论:pLEGFP-N1-hFⅨ能有效地转导hUCT-MSCs,并在其子代细胞中表达具有凝血活性的hFⅨ,这为hUCT-MSCs成为血友病B基因治疗的细胞载体研究奠定了基础。 展开更多
关键词 逆转录病毒 人凝血因子 人脐带组织源间充质干细胞 基因治疗 血友病B
下载PDF
人源载体pHrnF9介导的凝血因子Ⅸ基因在肠上皮sw480细胞中的表达 被引量:2
5
作者 杜建伟 陈方平 +2 位作者 夏昆 文路 宋永平 《中国实验血液学杂志》 CAS CSCD 2008年第4期878-882,共5页
本研究探索肠上皮细胞和人源载体pHrnFⅨ用于血友病B基因治疗的可能性。用含人凝血因子Ⅸ(human coagulation factorⅨ,hFⅨ)基因的人源载体质粒pHrnF9转染肠上皮细胞sw480,用RT-PCR检测mRNA的转录,荧光显微镜观察转染效率,ELISA和一期... 本研究探索肠上皮细胞和人源载体pHrnFⅨ用于血友病B基因治疗的可能性。用含人凝血因子Ⅸ(human coagulation factorⅨ,hFⅨ)基因的人源载体质粒pHrnF9转染肠上皮细胞sw480,用RT-PCR检测mRNA的转录,荧光显微镜观察转染效率,ELISA和一期法检测蛋白表达及凝血活性。结果表明:转染后的细胞中有hFⅨmRNA的转录;荧光显微镜观察到48小时转染效率最高;ELISA法测得转染后24小时细胞上清中的hFⅨ蛋白量为(11.34±0.23)ng/(106cells.24h),第48小时hFⅨ蛋白量最高,达(29.34±1.00)ng/(106cells.24h),转染后72小时降为(12.45±0.15)ng)/(106cells.24h)。一期法结果显示转染pHrnF9的sw480细胞分泌的FⅨ有凝血活性,48小时达峰值(6.07±0.17)%/106cells,第72小时降至(1.81±0.06)%/106cells。结论:肠上皮细胞sw480转染pHrnF9质粒后可表达有凝血活性的hFⅨ,肠上皮细胞有望成为血友病B基因治疗的靶细胞。 展开更多
关键词 肠上皮细胞sw480 人源载体pHrnF9 凝血因子 基因治疗
下载PDF
直接注射含人Ⅸ因子cDNA质粒在小鼠体内的表达 被引量:1
6
作者 卢珂 邱信芳 薛京伦 《癌变.畸变.突变》 CAS CSCD 1994年第1期1-5,共5页
本文报道了2种分别由人巨细胞病毒(hCMV)启动子和SV40早期启动子控制的人Ⅸ因子cDNA质粒pCMV─Ⅸ,pKG5─Ⅸ直接注射小鼠骨骼肌内,在肌细胞中可产生Ⅸ因子蛋白,并分泌至血液中,在注射后约第10d表达量最高... 本文报道了2种分别由人巨细胞病毒(hCMV)启动子和SV40早期启动子控制的人Ⅸ因子cDNA质粒pCMV─Ⅸ,pKG5─Ⅸ直接注射小鼠骨骼肌内,在肌细胞中可产生Ⅸ因子蛋白,并分泌至血液中,在注射后约第10d表达量最高,最高含量可达25ng/ml。为采用直接注射法进行遗传病基因治疗提供1种可能。 展开更多
关键词 基因表达 凝血因子 基因疗法 注射
下载PDF
内含子在人凝血Ⅸ因子反转录病毒载体中的表达及剪接作用
7
作者 邢永娜 卢大儒 +2 位作者 高晓波 邱信芳 薛京伦 《Acta Genetica Sinica》 SCIE CAS CSCD 1998年第6期471-477,共7页
构建了带有内含子的反转录病毒表达载体,研究内含子对hFⅨ的表达影响。反转录病毒载体经过PA317细胞包装后,稳定保留内含子是进一步研究内含子对hFⅨ表达影响的关键。首先构建了GlNaC-i-Ⅸ、GlNaC-i'-Ⅸ表达元件正向插入的反... 构建了带有内含子的反转录病毒表达载体,研究内含子对hFⅨ的表达影响。反转录病毒载体经过PA317细胞包装后,稳定保留内含子是进一步研究内含子对hFⅨ表达影响的关键。首先构建了GlNaC-i-Ⅸ、GlNaC-i'-Ⅸ表达元件正向插入的反转录病毒载体。其中,GlNaC-i-Ⅸ带有源于IL-2的异源内含子,GlNaC-i'-Ⅸ带有来自hFⅨ自身的第一内含子;其中间部分顺序缺失,只包括剪接供体和剪接受体位点。用RT-PCR方法发现,反转录病毒介导基因转移的载体中的内含子都被剪切掉。为避免内含子的剪切,又构建了表达元件反向插入的反转录病毒载体GlNaC-i'-ⅨR、GlNaPAi'ⅨBAM。用同样的方法证明,反向插入载体中的内含子被保留下来。证明表达元件反向插入的反转录病毒载体可以得到稳定的含有内含子的表达载体,ELISA检测证明内含子能提高hFⅨ表达。为进一步提高hFⅨ在体外细胞和体内的表达水平提供依据。 展开更多
关键词 内含子 反转录病毒载体 血友病B hfIX
下载PDF
人凝血Ⅸ因子cDNA在培养细胞中和转基因小鼠内的表达特性
8
作者 胡以平 邱信芳 +1 位作者 薛京伦 刘祖洞 《Acta Genetica Sinica》 SCIE CAS CSCD 1995年第3期161-166,共6页
将由SV40早期启动子和小鼠金属硫蛋白基因启动子所控制的人凝血Ⅸ因子cDNA的重组基因分别导入培养的小鼠成纤维细胞,发现它们都能被表达。进而将它们分别导入小鼠受精卵雄原核,作成相应的转基因小鼠,则发现它们都失去了表达... 将由SV40早期启动子和小鼠金属硫蛋白基因启动子所控制的人凝血Ⅸ因子cDNA的重组基因分别导入培养的小鼠成纤维细胞,发现它们都能被表达。进而将它们分别导入小鼠受精卵雄原核,作成相应的转基因小鼠,则发现它们都失去了表达特性,结果分析表明,在人凝血Ⅸ因子cDNA中可能存在着决定其在活体内表达的顺式调节元件。 展开更多
关键词 基因治疗 人凝因IX因子 CDNA 转基因小鼠
下载PDF
反转录病毒载体G_1NaCⅨ的构建及其在离体细胞中的表达
9
作者 章红 卢大儒 +5 位作者 江紫生 汪泱 江全 袁铿 邱信芳 薛京伦 《江西医学检验》 1998年第3期124-126,共3页
目的构建高效、安全、可用于基因治疗的反转录病毒载体G1NaCⅨ。方法用限制性内切酶Bg1Ⅱ和HindⅢ将CMV-FⅨcDNA从质粒pCMVⅨ-10上切下,将该片段与BamHⅠ和HindⅢ双酶切后的G1Na连接,连接后的载体经鉴定连接正确后即为新载体G1Nac... 目的构建高效、安全、可用于基因治疗的反转录病毒载体G1NaCⅨ。方法用限制性内切酶Bg1Ⅱ和HindⅢ将CMV-FⅨcDNA从质粒pCMVⅨ-10上切下,将该片段与BamHⅠ和HindⅢ双酶切后的G1Na连接,连接后的载体经鉴定连接正确后即为新载体G1NacⅨ,将G1NaCⅨ通过包装细胞PA317导入小鼠成纤维细胞NIH3T3、小鼠成肌细胞C2C12和人纤维肉瘤细胞HT1080中,选择培养两周后分别测定G1NaCⅨ在上述细胞中的Ⅸ因子表达量。结果(1)经酶切电泳鉴定,G1NaCⅨ连接正确;(2)G1NaCⅨ在N1H3T3中的Ⅸ因子表达量为60ng/106细胞·天-1,在C2C12中的Ⅸ因子表达量为1580ng/106细胞·天-1,在HT1080中的Ⅸ因子表达量为3600ng/106细胞·天-1,其中80%~90%的Ⅸ因子具有凝血活性。结论构建成功的反转录病毒载体G1NaCⅨ在C2C12和HT1080细胞中均能高效表达。 展开更多
关键词 反转录病毒载体 细胞 小鼠 CMV 表达 HT NIH 因子 正确 片段
下载PDF
HIGH EFFICIENT TRANSFER AND EXPRESSION OF HUMAN CLOTTING FACTOR Ⅸ cDNA IN CULTURED HUMAN PRIMARY SKIN FIBROBLASTS FROM HEMOPHILIA B PATIENT BY RETROVIRAL VECTORS 被引量:2
10
作者 戴一凡 邱信芳 +1 位作者 薛京伦 刘祖洞 《Science China Chemistry》 SCIE EI CAS 1992年第2期183-193,共11页
To study the possibility of somatic gene therapy for hemophilia B via gene transfer to primary factor Ⅸ-deficient skin fibroblasts, we constructed four retroviral vectors containing factor Ⅸ cDNA driven by retrovira... To study the possibility of somatic gene therapy for hemophilia B via gene transfer to primary factor Ⅸ-deficient skin fibroblasts, we constructed four retroviral vectors containing factor Ⅸ cDNA driven by retroviral LTR promoter, SV40 early promoter and mouse MT-I promoter, respectively. These retroviral vectors were transfected into an amphotropic packaging cell line, PA317 cells, by electroporation, and a human iibrosarcoma cell line, HT1080 cells, was used to assay the factor Ⅸ-virus titers of these four virus-producing PA317 cells, which ranged from 2×10~4 to 5×10~5 cfu/ml. The factor Ⅸ proteins produced by bulk population of four virus-producing PA317 cells were determined by ELISA. Results showed that LTR promoter directed the highest production of factor Ⅸ at the rate of 584 rig/10~6 cells/24h, while SV40 early promoter and MT promoter directed about 10 and 20 times less production of factor Ⅸ than LTR promoter. The highest expressed retroviral vector XL-Ⅸ was used to infect a line of 展开更多
关键词 gene therapy RETROVIRAL vector clotting factor .
原文传递
High expression of human clotting factor IX cDNA in myoblasts C2C12 cells and C3H mice 被引量:2
11
作者 王宏伟 包赟 +3 位作者 卢大儒 邱信芳 JerryL.Hsueh 薛京伦 《Science China(Life Sciences)》 SCIE CAS 1997年第4期371-378,共8页
Mouse myoblast C2C12 cell was used as target cell for gene transfer study of human clotting factor IX (hFIX) cDNA. In addition to the previously constructed retroviral vectors XLIX, LNCIX and GINaCIX, GlNaMCIX with hF... Mouse myoblast C2C12 cell was used as target cell for gene transfer study of human clotting factor IX (hFIX) cDNA. In addition to the previously constructed retroviral vectors XLIX, LNCIX and GINaCIX, GlNaMCIX with hFIX driven by muscle creatine kinase (MCK) enhancer and human cytomegalovirus (CMV) was constructed, based on the retroviral vector GINa. These four retroviral vectors were used to transduce mouse my-oblasts C2C12. With ELISA assays, it has been found that the expression levels of human clotting factor IX detected in those transduced C2C12 cells are GlNaMCIX】GlNaCIX】 LNCIX】XLIX. Mixed colonal cells transduced with GlNaMCIX expressed hFIX protein at the level of 640 ng/106 cell every 24 h. The modified C2C12 cells transduced with GlNaMCIX were implanted into skeletal muscle of the hindlegs of C3H mice; a stable expression of hFIX was detected and lasted for 35 d, with a maximum level of 206 ng/mL plasma. The regulation of hFIX cDNA expression in myoblasts was discussed and it was strongly 展开更多
关键词 MYOBLASTS human clotting factor GENE transfer GENE therapy.
原文传递
TRANSFER AND EXPRESSION OF HUMAN CLOTTING FACTOR IX GENE IN CHINESE HAMSTER OVARY CELLS 被引量:1
12
作者 戴一凡 刘坚 +1 位作者 邱信芳 薛京伦 《Chinese Science Bulletin》 SCIE EI CAS 1990年第1期60-63,共4页
Clotting factor Ⅸ is an essential member in the intrinsic dotting pathway and its defect may cause an inherited X-chromosome linked bleeding disorder——hemophilia B, or Christmas disease. Factor Ⅸ is synthesized in... Clotting factor Ⅸ is an essential member in the intrinsic dotting pathway and its defect may cause an inherited X-chromosome linked bleeding disorder——hemophilia B, or Christmas disease. Factor Ⅸ is synthesized in liver hepatocytes where it undergoes complex vitamin K-dependent post-translational modifications which are essential for the activation of factor Ⅸ. Recently, several groups have cloned factor Ⅸ cDNA and reported that, in the presence of vitamin K, active factor Ⅸ could be secreted in human and mouse fibroblasts, 展开更多
关键词 clotting factor GENE transfer.
原文传递
Long-Term Expression of Human Factor Ⅸ cDNA in Rabbits
13
作者 周洁民 邱信芳 +2 位作者 卢大儒 陆建英 薛京伦 《Science China Chemistry》 SCIE EI CAS 1993年第11期1333-1341,共9页
In this study, rabbits were used as a model for gene therapy for hemophilia B, Human factor Ⅸ cDNA was transferred to cultured normal rabbit skin fibroblasts (RSF) by a recombinant plasmid (pCMVIX) or retrovirus(XL-I... In this study, rabbits were used as a model for gene therapy for hemophilia B, Human factor Ⅸ cDNA was transferred to cultured normal rabbit skin fibroblasts (RSF) by a recombinant plasmid (pCMVIX) or retrovirus(XL-IX or N2CMVIX) constructed in our laboratoy. Infected fibroblasts capable of synthesizing and secreting high levels of biologically active human factor Ⅸ protein were selected and embedded in a collagen matrix. The latter was surgically implanted into rabbits as autografts or allografts. Human factor Ⅸ protein was detected in the plasma of all the grafted rabbits, and its expression has been maintained for more than 10 months at the time of writing. In addition, we have improved and simplified the method of implantation from surgically grafting the tissue-like matrix to the injection of the infected cell-collagen mixture subcutaneously. Using the latter method, human factor Ⅸ in rabbits injected with RSF-N2CMVIX reached a peak of 480 ng/ml plasma, and its expression has continued for 展开更多
关键词 GENE transfer GENE therapy human clotting factor cell-collagen injection expression in rabbit.
原文传递
RAPID DETECTION OF EXOGENOUS HUMAN CLOTTING FACTOR IX cDNA IN TRANSFERRED CELLS BY POLYMERASE CHAIN REACTION
14
作者 周洁民 戴一凡 +1 位作者 邱信芳 薛京伦 《Chinese Science Bulletin》 SCIE EI CAS 1990年第23期1995-1999,共5页
Polymerase chain reaction (PCR) is a recently devoloped molecular biological technique, using specific oligonucleotide primers and DNA polymerase to amplify the specific fragment of DNA in vitro. This technique has be... Polymerase chain reaction (PCR) is a recently devoloped molecular biological technique, using specific oligonucleotide primers and DNA polymerase to amplify the specific fragment of DNA in vitro. This technique has been successfully introduced in gene diagnosis, mutation detection, polymorphism analysis and nucleotide sequencing. In the study of gene transfer and gene therapy, it is necessary to analyse DNA in the 展开更多
关键词 POLYMERASE chain reaction human clotting factor CDNA EXOGENOUS CDNA detection.
原文传递
High expression of human clotting factor IX cDNA in the bone marrow stroma cells of hemophilia B patient
15
作者 卢大儒 邱信芳 +1 位作者 郑冰 薛京伦 《Chinese Science Bulletin》 SCIE EI CAS 1995年第16期1374-1377,共4页
Hemophilia B, a serious bleeding disorder, is an inherited X chromosome-linked diseasecaused by the deficiency or inactiveness of human clotting factor IX (FIX). The conven-tional clinical treatment of plasma infusion... Hemophilia B, a serious bleeding disorder, is an inherited X chromosome-linked diseasecaused by the deficiency or inactiveness of human clotting factor IX (FIX). The conven-tional clinical treatment of plasma infusion is expensive and associated with a high risk 展开更多
关键词 human clotting factor RETROVIRAL vector BONE MARROW stroma CELLS gene transfer.
原文传递
重组AAV2/hFⅨ病毒制备及其基因治疗血友病B的实验研究 被引量:4
16
作者 彭建强 董小岩 +6 位作者 彭忞 陈立 谭淑萍 袁洪 陈方平 薛京伦 吴小兵 《中华血液学杂志》 CAS CSCD 北大核心 2004年第9期513-518,共6页
目的 制备携带人凝血因子Ⅸ (hFⅨ )基因的重组AAV2病毒 (rAAV2 /hFⅨ ) ,并对用rAAV2 /hFⅨ肌肉注射治疗血友病B模型小鼠的疗效进行评价。方法 通过“一株载体细胞 /一株辅助病毒”的双因素包装策略制备出rAAV2 /hFⅨ ,体外转导BHK ... 目的 制备携带人凝血因子Ⅸ (hFⅨ )基因的重组AAV2病毒 (rAAV2 /hFⅨ ) ,并对用rAAV2 /hFⅨ肌肉注射治疗血友病B模型小鼠的疗效进行评价。方法 通过“一株载体细胞 /一株辅助病毒”的双因素包装策略制备出rAAV2 /hFⅨ ,体外转导BHK 2 1、C2C12细胞后 ,检测细胞培养上清中hFⅨ的表达量 ;肌肉直接注射血友病B模型小鼠后 ,检测其血浆中hFⅨ的抗原水平和凝血活性等指标。结果 转导 2 4h后在细胞上清中即可检测到hFⅨ ,连续检测 12 0h都有表达 ,BHK 2 1、C2C12细胞 2 4h最高表达量分别达到 (5 1.0± 6 .5 )ng/ 10 5细胞和 (6 8.0± 7.2 )ng/ 10 5细胞。rAAV2 /hFⅨ经肌肉直接注射后 ,高、中、低三个剂量组均能检测到小鼠体内高效表达hFⅨ ,在给药后第 3周达到高峰 ,小鼠血浆中hFⅨ的表达量与对照组比较差异有显著性 (P <0 .0 1) ,之后缓慢下降 ,到第 10周仍可检测到低水平hFⅨ表达 ;取第 3周小鼠血浆样品检测凝血功能 ,高、中、低剂量组FⅨ活性均得到明显改善 ,小鼠的割尾实验出血时间明显缩短 ,5min失血量也相应显著减少 ,其中高剂量组hFⅨ最高表达量达到 (387.0± 12 .5 )ng/ml血浆 ,FⅨ活性达到正常水平的 (30 .0± 5 .5 ) % ;给药后第 10周 ,除在注射点外 ,其它主要脏器均未检测到AAV载体DNA。 展开更多
关键词 血友病B 血浆 模型小鼠 基因治疗 表达量 C2C12细胞 转导 高效表达 凝血因子 高表达
原文传递
Building of hFⅨ transgenic mice by spermatogenic cells 被引量:2
17
作者 WANG Ning, CHEN Xiaoguang, CHEN Li, YAO Jihua, CHEN Haoming, SHEN Qi & XUE Jinglun State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai 200433, China Correspondence should be addressed to Xue Jinglun (e-mail: jlxue @fudan.ac.cn) 《Chinese Science Bulletin》 SCIE EI CAS 2003年第19期2061-2063,共3页
Human FⅨ expression vector pCMVⅨ was packaged by EffecteneTM reagent and injected into mice seminiferous tubules with glass pipettes. The expressional frame of pCMVⅨ was examined by PCR and Southern blotting among ... Human FⅨ expression vector pCMVⅨ was packaged by EffecteneTM reagent and injected into mice seminiferous tubules with glass pipettes. The expressional frame of pCMVⅨ was examined by PCR and Southern blotting among 41 progenies. There were 2 (4%) mice being integrated with hFⅨ gene into chromosomes. 4.6 ng/mL of hFⅨ protein was expressed in plasma of one mouse, which was tested by ELISA. We demonstrated that building of transgenic animals by spermatogonial stem cells is an efficient method. Meanwhile, it has also been proved to be an alternative choice for mammary gland bioreactor. 展开更多
关键词 基因转录老鼠 精子生成细胞 抗血友病因子 F 表达载体 pCMV 乳腺生物反应器
原文传递
Preparation of rAAV/hFⅨ by HSV/AAV hybrid helper virusand evaluation of its safety
18
作者 CHENLi CHENHaoming +4 位作者 ZOUBeiyan WUZhijian WUXiaobing LUDaru XUEJinglun 《Chinese Science Bulletin》 SCIE EI CAS 2003年第13期1369-1374,共6页
The recombinant adeno-associated viral vector with human coagulation Factor Ⅸ minigene which wasregulated by CMV promoter was constructed. Largequantity of recombinant adeno-associated viral particles (rAAV/ hFⅨ) wa... The recombinant adeno-associated viral vector with human coagulation Factor Ⅸ minigene which wasregulated by CMV promoter was constructed. Largequantity of recombinant adeno-associated viral particles (rAAV/ hFⅨ) was prepared by the HSV/AAV hybrid helper virus method. Southern dot blot assay and QC-PCR indicated that the titer of the virus was 3.6×1012 v.g./mL. It demonstrated that this method can effectively overcome the hurdles of mass production of AAV vector. Followed by anintramuscular injection of viral vectors (7.5×1011 v.g./mouse) in the quadriceps femoris, an elevation of human Factor Ⅸexpression in the plasma of hemophilia B mice was detected (387 ng/mL) and persisted more than 12 weeks. The level of anti-virus antibody in plasma aligned with the Factor Ⅸexpression curve. The QC-PCR method is easier and moreaccurate than traditional dot hybridization fordetermination of the titer of recombinant adeno-associated virus. Moreover, there are no HSV particles existing inproduced AAV assayed by RT-PCR. AAV is the only virus that has been amplified from AAV-injected muscle by PCR. 展开更多
关键词 rAAV/hf HSV/AAV 重组体 辅助病毒 血友病 基因治疗
原文传递
人凝血Ⅸ因子乳腺生物反应器的研制 被引量:8
19
作者 邱信芳 张克忠 +1 位作者 卢大儒 薛京伦 《复旦学报(自然科学版)》 CAS CSCD 北大核心 1998年第4期365-371,共7页
为了建立人凝血Ⅸ因子乳腺生物反应器,以MCK增强子,β-actin启动于控制hFIX小基因(minigene)表达顺序,反向插入G1Na框架,构建复制缺陷反转录病毒载体,并制备重组反转录病毒颗粒;以CMV启动子,hFIXcDNA和腺病毒框架构建腺病毒载... 为了建立人凝血Ⅸ因子乳腺生物反应器,以MCK增强子,β-actin启动于控制hFIX小基因(minigene)表达顺序,反向插入G1Na框架,构建复制缺陷反转录病毒载体,并制备重组反转录病毒颗粒;以CMV启动子,hFIXcDNA和腺病毒框架构建腺病毒载体pAdCMVhFIX,与质粒pJM17共转染包装细胞制备合hFIX基因的重组腺病毒颗粒.两种病毒颗粒分别通过直接转染活体奶山羊乳腺组织,建立了hFIX蛋白的乳腺表达系统和快速检测系统.另外,利用小鼠MAR(matrixattachmentregion)元件,牛β-Casein基因,人凝血Ⅸ因子小基因和cDNA构建了乳腺组织特异性表达载体.以Stearylamine(SA)阳离子脂质体介导、尾静脉注射的方法转染哺乳期雌性小鼠的活体组织,建立Ⅸ因子表达的快速检测系统,并研究了β-casein基因,hFIX基因intron1对hFIX基因在乳腺组织中表达调控的作用.在此基础上将筛选得到的pMCIXm表达载体通过显微注射技术注人小鼠和奶山羊受精卵细胞,制备6只转基因小鼠和5只转基因奶山羊.其中在2只转基因小鼠和1头奶山羊乳汁中测得hFIX蛋白的表达并具有凝血活性. 展开更多
关键词 人凝血因子 乳腺生物反应器 转基因动物
原文传递
人凝血Ⅸ因子乳腺特异性表达载体在离体细胞和小鼠乳腺组织中表达的初步研究 被引量:4
20
作者 张克忠 崇松 +3 位作者 陈立 卢大儒 薛京伦 邱信芳 《复旦学报(自然科学版)》 CAS CSCD 北大核心 1998年第4期527-531,共5页
以小鼠MAR(matrixattachmentregion)元件,牛β-酪蛋白(β-casein)基因5'端2.0kb调控顺序,人凝血Ⅸ因子小基因(hFIXminigene)构建乳腺组织特异性表达载体,表达载体和质粒pSV-neo共转染中国仓鼠卵巢细胞(CHO),兔皮肤纤... 以小鼠MAR(matrixattachmentregion)元件,牛β-酪蛋白(β-casein)基因5'端2.0kb调控顺序,人凝血Ⅸ因子小基因(hFIXminigene)构建乳腺组织特异性表达载体,表达载体和质粒pSV-neo共转染中国仓鼠卵巢细胞(CHO),兔皮肤纤维细胞(RSF)和人胚肾上皮细胞(293细胞).发现hFIX基因在CHO细胞中获得低水平表达,最高表达量为7.2ng/ml.在皮肤成纤维细胞中的表达量低于2ng/ml.在293细胞中没有表达.表达载体用stearylamine(SA)脂质体包埋后尾静脉注射哺乳期小鼠,hFIX蛋白在小鼠乳汁中表达水平高达87.34ng/ml. 展开更多
关键词 人凝血因子 乳腺组织 基因表达 载体
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部